New Insights into Early Detection and Impact of Diabetes on Eye Health
UCL scientists have identified the protein LRG1 as a key early trigger of diabetic retinopathy, suggesting that targeting this protein could prevent vision loss in people with diabetes before irreversible damage occurs. A drug targeting LRG1 is already in pre-clinical development, offering hope for more effective early intervention compared to current treatments.